You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 22, Dec 13/27, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Prognostic Impact of Oral Anticoagulant Treatment in Patients With Intracerebral Hemorrhage—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We agree that hematoma volume and level of consciousness on admission are important predictors of in-hospital mortality from ICH. Indeed, as we discussed, a plausible mechanism for the effect of warfarin sodium on ICH mortality is through the generation of larger hematoma volumes.1 We have investigated this question in a follow-up study and found that while patients receiving warfarin do not have larger hemorrhage volumes on presentation, they do have an increased risk of in-hospital expansion of these volumes.2 Notably, the effect of warfarin on mortality was independent of level of consciousness on admission.

Neurosurgical intervention occurred in fewer than 10% of patients in our cohort and did not affect the relationship between warfarin and mortality. It is in fact far from clear that neurosurgical intervention has any effect on outcome in supratentorial ICH.3-4 This contrasts with cerebellar ICH, a disease not included in our study, for which . . . [Full Text of this Article]


AUTHOR INFORMATION
Jonathan Rosand, MD; Steven M. Greenberg, MD, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

The Prognostic Impact of Oral Anticoagulant Treatment in Patients With Intracerebral Hemorrhage
Ulrich Thiem, Christoph Friedrich, Gerd Deutschinoff, and Ludger Pientka
Arch Intern Med. 2004;164(22):2504-2505.
EXTRACT | FULL TEXT  

The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
Jonathan Rosand, Mark H. Eckman, Katherine A. Knudsen, Daniel E. Singer, and Steven M. Greenberg
Arch Intern Med. 2004;164(8):880-884.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.